Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity

Current Gastroenterology Reports

Volumn 18, Issue 7, 2016, Pages

  Escudero Hernández, Celia ^a   Peña, Amado Salvador ^b   Bernardo, David ^c  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

Author keywords

Celiac disease; Gluten free diet; Non celiac gluten sensitivity; Oral tolerance; Pathogenesis

Indexed keywords

ANTIBODY; BL 7010; GASTROINTESTINAL AGENT; GLUTEN ANTIBODY; HLA DQ ANTIGEN; INTERLEUKIN 15; LATIGLUTENASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG; GLUTEN;

ANTIGEN PRESENTATION; CELIAC DISEASE; CELLULAR IMMUNITY; DENDRITIC CELL; DISEASE PREDISPOSITION; EPIGENETICS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLUTEN FREE DIET; HUMAN; IMMUNOGENETICS; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA; INTESTINE VILLUS ATROPHY; LAMINA PROPRIA; NON CELIAC GLUTEN SENSITIVITY; NUTRITIONAL INTOLERANCE; PROTEIN DEGRADATION; QUANTITATIVE TRAIT LOCUS; REVIEW; SIGNAL TRANSDUCTION; SOCIAL LIFE; WELLBEING; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; MICROBIOLOGY; WHEAT ALLERGY;

CELIAC DISEASE; DIET, GLUTEN-FREE; EPIGENESIS, GENETIC; GASTROINTESTINAL MICROBIOME; GLUTENS; HUMANS; IMMUNOGENETIC PHENOMENA; WHEAT HYPERSENSITIVITY;

EID: 84969940846     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-016-0512-2     Document Type: Review

References (111)

1. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol. 2002;2(9):647–55. doi:10.1038/nri885.
2. Koehler P, Wieser H. Chemistry of cereal grains. In: Gobbetti M, Gänzle M, editors. Handbook on Sourdough Biotechnology. Springer; 2013. p. 11–45.
3. Comino I, Real A, de Lorenzo L, Cornell H, Lopez-Casado MA, Barro F, et al. Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease. Gut. 2011;60(7):915–22. doi:10.1136/gut.2010.225268.
4. Comino I, Bernardo D, Bancel E, de Lourdes MM, Sanchez B, Barro F, et al. Identification and molecular characterization of oat peptides implicated on coeliac immune response. Food Nutr Res. 2016;60:30324. doi:10.3402/fnr.v60.30324.
5. Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128(4 Suppl 1):S57–67.
6. Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136–60. doi:10.1097/MPG.0b013e31821a23d0.
7. Lerner A, Matthias T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev. 2015;14(6):479–89. doi:10.1016/j.autrev.2015.01.009.
8. Memon Z, Baker SS, Khan A, Hashmi H, Gelfond D. An orthodontic retainer preventing remission in celiac disease. Clin Pediatr. 2013;52(11):1034–7. doi:10.1177/0009922813506254.
9. Lanzini A, Lanzarotto F, Villanacci V, Mora A, Bertolazzi S, Turini D, et al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther. 2009;29(12):1299–308. doi:10.1111/j.1365-2036.2009.03992.x.
10. Barratt SM, Leeds JS, Sanders DS. Quality of life in Coeliac Disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved. J Gastrointestin Liver Dis. 2011;20(3):241–5.
11. Hadithi M, Peña AS. Current methods to diagnose the unresponsive and complicated forms of coeliac disease. Eur J Intern Med. 2010;21(4):247–53. doi:10.1016/j.ejim.2010.01.015.
12. De Andres A, Camarero C, Roy G. Distal duodenum versus duodenal bulb: intraepithelial lymphocytes have something to say in celiac disease diagnosis. Dig Dis Sci. 2015;60(4):1004–9. doi:10.1007/s10620-014-3414-x.
13. Peña AS. What is the best histopathological classification for celiac disease? Does it matter? Gastroenterol Hepatol Bed Bench. 2015;8(4):239–43. Evaluation of the propossed classifications for the histological assessment of duodenal biopsies for the consideration of celiac disease.
14. Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol. 2011;29:493–525. doi:10.1146/annurev-immunol-040210-092915.
15. Bernardo D. Human intestinal dendritic cells as controllers of mucosal immunity. Rev Esp Enferm Dig Organo Off Soc Esp Patol Dig. 2013;105(5):279–90.
16. Stamnaes J, Sollid LM. Celiac disease: autoimmunity in response to food antigen. Semin Immunol. 2015;27(5):343–52. doi:10.1016/j.smim.2015.11.001. Review of current knowledge on the adaptive immune processes in CD, particularly the role of TG2 and B-cells.
17. Nilsen EM, Jahnsen FL, Lundin KE, Johansen FE, Fausa O, Sollid LM, et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology. 1998;115(3):551–63.
18. Salvati VM, MacDonald TT, Bajaj-Elliott M, Borrelli M, Staiano A, Auricchio S, et al. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut. 2002;50(2):186–90.
19. Fina D, Sarra M, Caruso R, Del Vecchio BG, Pallone F, MacDonald TT, et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut. 2008;57(7):887–92. doi:10.1136/gut.2007.129882.
20. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 2004;21(3):357–66. doi:10.1016/j.immuni.2004.06.020.
21. Tang F, Chen Z, Ciszewski C, Setty M, Solus J, Tretiakova M, et al. Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. J Exp Med. 2009;206(3):707–19. doi:10.1084/jem.20071887.
22. Bernardo D, Garrote JA, Fernandez-Salazar L, Riestra S, Arranz E. Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides. Gut. 2007;56(6):889–90. doi:10.1136/gut.2006.118265.
23. Bernardo D, Garrote JA, Allegretti Y, Leon A, Gomez E, Bermejo-Martin JF, et al. Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients. Clin Exp Immunol. 2008;154(1):64–73. doi:10.1111/j.1365-2249.2008.03743.x.
24. Bernardo D, Peña AS. Developing strategies to improve the quality of life of patients with gluten intolerance in patients with and without coeliac disease. Eur J Intern Med. 2012;23(1):6–8. doi:10.1016/j.ejim.2011.09.016.
25. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med. 1989;169(1):345–50.
26. Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol. 2009;9(12):858–70. doi:10.1038/nri2670.
27. Sollid LM, Qiao SW, Anderson RP, Gianfrani C, Koning F. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics. 2012;64(6):455–60. doi:10.1007/s00251-012-0599-z.
28. Stagg AJ, Hart AL, Knight SC, Kamm MA. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut. 2003;52(10):1522–9.
29. Bernardo D, Knight SC. Mechanisms of intestinal tolerance to dietary proteins. In: Arranz E, Fernández-Bañares F, Rosell CM, Rodrigo L, Peña S, editors. Advances in the understanding of gluten related pathology and the evolution of gluten-free foods. OmniaScience; 2015. p. 105–39.
30. Persson EK, Scott CL, Mowat AM, Agace WW. Dendritic cell subsets in the intestinal lamina propria: ontogeny and function. Eur J Immunol. 2013;43(12):3098–107. doi:10.1002/eji.201343740.
31. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245–52. doi:10.1038/32588.
32. Hart AL, Ng SC, Mann E, Al-Hassi HO, Bernardo D, Knight SC. Homing of immune cells: role in homeostasis and intestinal inflammation. Inflamm Bowel Dis. 2010;16(11):1969–77. doi:10.1002/ibd.21304.
33. du Pre MF, Sollid LM. T-cell and B-cell immunity in celiac disease. Best Pract Res Clin Gastroenterol. 2015;29(3):413–23. doi:10.1016/j.bpg.2015.04.001. Review of antigen presentation and T-cell/B-cell cooperation in CD.
34. Kim SY. Transglutaminase 2 in inflammation. Front Biosci J Virtual Libr. 2006;11:3026–35.
35. Lebreton C, Menard S, Abed J, Moura IC, Coppo R, Dugave C, et al. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology. 2012;143(3):698–707 e1-4. doi:10.1053/j.gastro.2012.05.051.
36. Lock RJ, Stevens S, Pitcher MC, Unsworth DJ. Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease? Eur J Gastroenterol Hepatol. 2004;16(5):467–70.
37. Snir O, Mesin L, Gidoni M, Lundin KE, Yaari G, Sollid LM. Analysis of celiac disease autoreactive gut plasma cells and their corresponding memory compartment in peripheral blood using high-throughput sequencing. J Immunol. 2015;194(12):5703–12. doi:10.4049/jimmunol.1402611. This article describes the gut plasma cells on CD, the most relevant ones being the bias in the usage of IGHV genes and the low number of somatic hypermutations.
38. Di Niro R, Mesin L, Zheng NY, Stamnaes J, Morrissey M, Lee JH, et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med. 2012;18(3):441–5. doi:10.1038/nm.2656.
39. Bateman EA, Ferry BL, Hall A, Misbah SA, Anderson R, Kelleher P. IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin. Gut. 2004;53(9):1274–8. doi:10.1136/gut.2003.032755.
40. Fleckenstein B, Qiao SW, Larsen MR, Jung G, Roepstorff P, Sollid LM. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem. 2004;279(17):17607–16. doi:10.1074/jbc.M310198200.
41. Iversen R. Igs as substrates for transglutaminase 2: implications for autoantibody production in celiac disease. J Immunol. 2015;195(11):5159–68. doi:10.4049/jimmunol.1501363.
42. Iversen R, Di Niro R, Stamnaes J, Lundin KE, Wilson PC, Sollid LM. Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J Immunol. 2013;190(12):5981–91. doi:10.4049/jimmunol.1300183. Characterization of the particular events related to B-cell involvement on CD: the preferential activation of IgD-expressing B-cells and how TG2-scpecific B-cells could react with gluten and participate in the activation of gluten-reactive T-cells.
43. Cardoso I, Stamnaes J, Andersen JT, Melino G, Iversen R, Sollid LM. Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies. FEBS J. 2015;282(11):2063–75. doi:10.1111/febs.13276. Demonstration of TG2 interaction with extracellular matrix components such as fibronectin.
44. Budagian V, Bulanova E, Paus R, Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 2006;17(4):259–80. doi:10.1016/j.cytogfr.2006.05.001.
45. Abadie V, Jabri B. IL-15: a central regulator of celiac disease immunopathology. Immunol Rev. 2014;260(1):221–34. doi:10.1111/imr.12191.
46. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity. 2004;21(3):367–77. doi:10.1016/j.immuni.2004.06.018.
47. Deshpande P, Cavanagh MM, Le Saux S, Singh K, Weyand CM, Goronzy JJ. IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens. J Immunol. 2013;190(4):1416–23. doi:10.4049/jimmunol.1201620. Homeostatic cytokine levels have a role on autoimmune responses through sensitization of the TCR pathway via ERK phosphorylation.
48. Ohteki T, Suzue K, Maki C, Ota T, Koyasu S. Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. Nat Immunol. 2001;2(12):1138–43. doi:10.1038/ni729.
49. Mattei F, Schiavoni G, Belardelli F, Tough DF. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol. 2001;167(3):1179–87.
50. Benahmed M, Meresse B, Arnulf B, Barbe U, Mention JJ, Verkarre V, et al. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology. 2007;132(3):994–1008. doi:10.1053/j.gastro.2006.12.025.
51. Ben Ahmed M, Belhadj Hmida N, Moes N, Buyse S, Abdeladhim M, Louzir H, et al. IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway. J Immunol. 2009;182(11):6763–70. doi:10.4049/jimmunol.0801792.
52. Ludwig H, Polymenidis Z, Granditsch G, Wick G. Association of HL-A1 and HL-A8 with childhood celiac disease. Z Immunitatsforsch Exp Klin Immunol. 1973;146(2):158–67.
53. Vazquez H, de la Paz TM, Sugai E, Scacchi SM, Souza C, Cisterna D, et al. Prevalence of celiac disease and celiac autoimmunity in the Toba Native Amerindian community of Argentina. Can J Gastroenterol Hepatol. 2015;29(8):431–4.
54. Wang H, Zhou G, Luo L, Crusius JB, Yuan A, Kou J, et al. Serological screening for celiac disease in adult Chinese patients with diarrhea predominant irritable bowel syndrome. Medicine. 2015;94(42):e1779. doi:10.1097/MD.0000000000001779.
55. van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, Inouye M, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet. 2007;39(7):827–9. doi:10.1038/ng2058.
56. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. 2010;42(4):295–302. doi:10.1038/ng.543.
57. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011;43(12):1193–201. doi:10.1038/ng.998.
58. Farh KK, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015;518(7539):337–43. doi:10.1038/nature13835.
59. Kumar V, Gutierrez-Achury J, Kanduri K, Almeida R, Hrdlickova B, Zhernakova DV, et al. Systematic annotation of celiac disease loci refines pathological pathways and suggests a genetic explanation for increased interferon-gamma levels. Hum Mol Genet. 2015;24(2):397–409. doi:10.1093/hmg/ddu453.
60. Amundsen SS, Viken MK, Sollid LM, Lie BA. Coeliac disease-associated polymorphisms influence thymic gene expression. Genes Immun. 2014;15(6):355–60. doi:10.1038/gene.2014.26.
61. Fairfax BP, Humburg P, Makino S, Naranbhai V, Wong D, Lau E, et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science. 2014;343(6175):1246949. doi:10.1126/science.1246949.
62. Lee MN, Ye C, Villani AC, Raj T, Li W, Eisenhaure TM, et al. Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science. 2014;343(6175):1246980. doi:10.1126/science.1246980.
63. Plaza-Izurieta L, Fernandez-Jimenez N, Irastorza I, Jauregi-Miguel A, Romero-Garmendia I, Vitoria JC, et al. Expression analysis in intestinal mucosa reveals complex relations among genes under the association peaks in celiac disease. Eur J Hum Genet. 2015;23(8):1100–5. doi:10.1038/ejhg.2014.244. This article shows the complex relation between genetics and gene expression. Several eQTLs are related to CD, being also dependent on the presence of gluten in the diet of the CD patients.
64. Ricano-Ponce I, Wijmenga C. Mapping of immune-mediated disease genes. Annu Rev Genomics Hum Genet. 2013;14:325–53. doi:10.1146/annurev-genom-091212-153450.
65. Hrdlickova B, Kumar V, Kanduri K, Zhernakova DV, Tripathi S, Karjalainen J, et al. Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell-type specificity. Genome Med. 2014;6(10):88. doi:10.1186/s13073-014-0088-0.
66. Vaira V, Roncoroni L, Barisani D, Gaudioso G, Bosari S, Bulfamante G, et al. microRNA profiles in coeliac patients distinguish different clinical phenotypes and are modulated by gliadin peptides in primary duodenal fibroblasts. Clin Sci (Lond). 2014;126(6):417–23. doi:10.1042/CS20130248. Seven microRNAs are differentially regulated among CD individuals with distinct clinical phenotypes and are also modulated in presence of gliadin peptides.
67. Magni S, Buoli Comani G, Elli L, Vanessi S, Ballarini E, Nicolini G, et al. miRNAs affect the expression of innate and adaptive immunity proteins in celiac disease. Am J Gastroenterol. 2014;109(10):1662–74. doi:10.1038/ajg.2014.203.
68. Diosdado B, Buffart TE, Watkins R, Carvalho B, Ylstra B, Tijssen M, et al. High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas. Clin Cancer Res Off J Am Assoc Cancer Res. 2010;16(5):1391–401. doi:10.1158/1078-0432.CCR-09-1773.
69. Roostaee A, Guezguez A, Beausejour M, Simoneau A, Vachon PH, Levy E, et al. Histone deacetylase inhibition impairs normal intestinal cell proliferation and promotes specific gene expression. J Cell Biochem. 2015. doi:10.1002/jcb.25274.
70. Johnson IT, Belshaw NJ. The effect of diet on the intestinal epigenome. Epigenomics. 2014;6(2):239–51. doi:10.2217/epi.14.8.
71. Steegenga WT, Mischke M, Lute C, Boekschoten MV, Pruis MG, Lendvai A, et al. Sexually dimorphic characteristics of the small intestine and colon of prepubescent C57BL/6 mice. Biol Sex Differ. 2014;5:11. doi:10.1186/s13293-014-0011-9.
72. Ricano-Ponce I, Wijmenga C, Gutierrez-Achury J. Genetics of celiac disease. Best Pract Res Clin Gastroenterol. 2015;29(3):399–412. doi:10.1016/j.bpg.2015.04.004.
73. Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature. 2012;489(7415):231–41. doi:10.1038/nature11551.
74. Sanchez E, Laparra JM, Sanz Y. Discerning the role of Bacteroides fragilis in celiac disease pathogenesis. Appl Environ Microbiol. 2012;78(18):6507–15. doi:10.1128/AEM.00563-12.
75. Laparra JM, Sanz Y. Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion. J Cell Biochem. 2010;109(4):801–7. doi:10.1002/jcb.22459.
76. Caminero A, Herran AR, Nistal E, Perez-Andres J, Vaquero L, Vivas S, et al. Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease. FEMS Microbiol Ecol. 2014;88(2):309–19. doi:10.1111/1574-6941.12295.
77. Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol. 2007;56(Pt 12):1669–74. doi:10.1099/jmm.0.47410-0.
78. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMC Microbiol. 2008;8:232. doi:10.1186/1471-2180-8-232.
79. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol. 2009;62(3):264–9. doi:10.1136/jcp.2008.061366.
80. Nistal E, Caminero A, Vivas S, de Morales JM R, de Miera LE S, Rodriguez-Aparicio LB, et al. Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients. Biochimie. 2012;94(8):1724–9. doi:10.1016/j.biochi.2012.03.025.
81. De Palma G, Nadal I, Collado MC, Sanz Y. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br J Nutr. 2009;102(8):1154–60. doi:10.1017/S0007114509371767.
82. Wacklin P, Kaukinen K, Tuovinen E, Collin P, Lindfors K, Partanen J, et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis. 2013;19(5):934–41. doi:10.1097/MIB.0b013e31828029a9. Microbiota composition presents less diversity in CD patients with gastrointestinal symptoms than in control subjects or CD patients with extraintestinal symptoms. These patients have an increased population of Proteobacteria, while control subjects and patients with dermatitis herpetiformis have a more varied microbiota with a high abundance of Firmicutes.
83. Abt MC, Osborne LC, Monticelli LA, Doering TA, Alenghat T, Sonnenberg GF, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity. 2012;37(1):158–70. doi:10.1016/j.immuni.2012.04.011.
84. Ganal SC, Sanos SL, Kallfass C, Oberle K, Johner C, Kirschning C, et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity. 2012;37(1):171–86. doi:10.1016/j.immuni.2012.05.020.
85. Kawashima T, Kosaka A, Yan H, Guo Z, Uchiyama R, Fukui R, et al. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-beta. Immunity. 2013;38(6):1187–97. doi:10.1016/j.immuni.2013.02.024. Double-stranded RNA (dsRNA) from lactic acid bacteria induce the production of interferon-beta and protect mice from experimental colitis, while pathogenic bacteria, which contains less dsRNA, induce smaller amounts of interferon-beta. This is translated in TLR3 acting as a sensor that protects from immunological responses.
86. Re F, Strominger JL. Heterogeneity of TLR-induced responses in dendritic cells: from innate to adaptive immunity. Immunobiology. 2004;209(1–2):191–8. doi:10.1016/j.imbio.2004.03.005.
87. Di Cagno R, De Angelis M, De Pasquale I, Ndagijimana M, Vernocchi P, Ricciuti P, et al. Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol. 2011;11:219. doi:10.1186/1471-2180-11-219.
88. Volta U, Caio G, De Giorgio R, Henriksen C, Skodje G, Lundin KE. Non-celiac gluten sensitivity: a work-in-progress entity in the spectrum of wheat-related disorders. Best Pract Res Clin Gastroenterol. 2015;29(3):477–91. doi:10.1016/j.bpg.2015.04.006.
89. Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012;10:13. doi:10.1186/1741-7015-10-13.
90. Catassi C, Bai JC, Bonaz B, Bouma G, Calabro A, Carroccio A, et al. Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients. 2013;5(10):3839–53. doi:10.3390/nu5103839.
91. Biesiekierski JR, Newnham ED, Irving PM, Barrett JS, Haines M, Doecke JD, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol. 2011;106(3):508–14. doi:10.1038/ajg.2010.487. quiz 15.
92. Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013;145(2):320–8 e1-3. doi:10.1053/j.gastro.2013.04.051.
93. Di Sabatino A, Volta U, Salvatore C, Biancheri P, Caio G, De Giorgio R, et al. Small amounts of gluten in subjects with suspected nonceliac gluten sensitivity: a randomized, double-blind, placebo-controlled, cross-over trial. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2015;13(9):1604–12. doi:10.1016/j.cgh.2015.01.029. e3.
94. Zanini B, Basche R, Ferraresi A, Ricci C, Lanzarotto F, Marullo M, et al. Randomised clinical study: gluten challenge induces symptom recurrence in only a minority of patients who meet clinical criteria for non-coeliac gluten sensitivity. Aliment Pharmacol Ther. 2015;42(8):968–76. doi:10.1111/apt.13372. Double-blinded placebo-controlled cross-over gluten-challenge study on patients following a gluten-free diet. Only a third of the patients were identified as true non-celiac gluten sensitivity patients, while a significant amount of patients could be sensitive to Fermentable Oligo-Di-Monosaccharides and Polyols (FODMAPs).
95. Schuppan D, Pickert G, Ashfaq-Khan M, Zevallos V. Non-celiac wheat sensitivity: differential diagnosis, triggers and implications. Best Pract Res Clin Gastroenterol. 2015;29(3):469–76. doi:10.1016/j.bpg.2015.04.002.
96. Junker Y, Zeissig S, Kim SJ, Barisani D, Wieser H, Leffler DA, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med. 2012;209(13):2395–408. doi:10.1084/jem.20102660.
97. Rashtak S, Ettore MW, Homburger HA, Murray JA. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2008;6(4):426–32. doi:10.1016/j.cgh.2007.12.030. quiz 370.
98. Tursi A, Brandimarte G, Giorgetti GM. Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease. J Clin Gastroenterol. 2003;37(5):387–91.
99. Comino I, Real A, Vivas S, Siglez MA, Caminero A, Nistal E, et al. Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am J Clin Nutr. 2012;95(3):670–7. doi:10.3945/ajcn.111.026708.
100. Moreno ML, Cebolla A, Munoz-Suano A, Carrillo-Carrion C, Comino I, Pizarro A, et al. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut. 2015. doi:10.1136/gutjnl-2015-310148. Gluten immunogenic peptides (GIP) can be detected in urine samples for 1–2 days. This simple non-invasive test confirms that a great proportion of celiac disease patients do not follow a strict gluten-free diet.
101. Plugis NM, Khosla C. Therapeutic approaches for celiac disease. Best Pract Res Clin Gastroenterol. 2015;29(3):503–21. doi:10.1016/j.bpg.2015.04.005. Review of the new therapeutic approaches for celiac disease patients.
102. Lahdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Karja-Lahdensuu T, et al. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology. 2014;146(7):1649–58. doi:10.1053/j.gastro.2014.02.031.
103. Gujral N, Suh JW, Sunwoo HH. Effect of anti-gliadin IgY antibody on epithelial intestinal integrity and inflammatory response induced by gliadin. BMC Immunol. 2015;16:41. doi:10.1186/s12865-015-0104-1.
104. McCarville JL, Nisemblat Y, Galipeau HJ, Jury J, Tabakman R, Cohen A, et al. BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity. PLoS One. 2014;9(11):e109972. doi:10.1371/journal.pone.0109972.
105. Smecuol E, Hwang HJ, Sugai E, Corso L, Chernavsky AC, Bellavite FP, et al. Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease. J Clin Gastroenterol. 2013;47(2):139–47. doi:10.1097/MCG.0b013e31827759ac.
106. Croese J, Giacomin P, Navarro S, Clouston A, McCann L, Dougall A, et al. Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease. J Allergy Clin Immunol. 2015;135(2):508–16. doi:10.1016/j.jaci.2014.07.022.
107. Bickston SJ, Behm BW, Tsoulis DJ, Cheng J, MacDonald JK, Khanna R, et al. Vedolizumab for induction and maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2014;8:CD007571. doi:10.1002/14651858.CD007571.pub2.
108. Zhao J, de Vera J, Narushima S, Beck EX, Palencia S, Shinkawa P, et al. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Gastroenterology. 2007;132(4):1331–43. doi:10.1053/j.gastro.2007.02.001.
109. Gopalakrishnan S, Durai M, Kitchens K, Tamiz AP, Somerville R, Ginski M, et al. Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides. 2012;35(1):86–94. doi:10.1016/j.peptides.2012.02.015.
110. Senger S, Luongo D, Maurano F, Mazzeo MF, Siciliano RA, Gianfrani C, et al. Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice. Immunol Lett. 2003;88(2):127–34.
111. Anderson RP, Jabri B. Vaccine against autoimmune disease: antigen-specific immunotherapy. Curr Opin Immunol. 2013;25(3):410–7. doi:10.1016/j.coi.2013.02.004.